PREVALENCE AND EFFECT OF IRON DEFICIENCY ANEMIA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Authors

  • Taha Othman Mahwi College of Medicine, University of Sulaimani, Kurdistan Region, Iraq.
  • Blnd Ahmad Aziz General Internal Medical hospital, Sulaimani, Kurdistan Region, Iraq.

DOI:

https://doi.org/10.17656/jsmc.10259

Keywords:

Iron deficiency anemia, COPD, Exacerbation COPD, Chronic obstructive pulmonary disease

Abstract

Background 

Anemia is progressively recognized as significant comorbidity in the context of chronic obstructive pulmonary disease (COPD). 

Objectives 

To determine the extent of iron deficiency anemia in both exacerbation of COPD and stable COPD.

Patients and Methods

A prospective, multicenter, cross-sectional study was conducted between April 2017 and January 2018. Two groups of patients were enrolled, group A included those patients admitted in the emergency rooms for the management of acute exacerbation of COPD and group B comprised of those patients with stable COPD visited the consultatory medical department. Inclusion criteria included those patients known cases of COPD and categorized according to the GOLD criteria. 

Results

The study included 150 patients. Group A contained 100 patients. Seventy-nine (79%) were male with a mean age and standard deviation of 66.77 years ± 12.07 years. While the other groups (group B) comprised of 50 patients, 39 (78%) were male with a mean age of 59.86 years ± 9.87 years. The inflammatory marker was significantly more positive in group A (89, 89%) compared to group B (6, 12%), P-value 0.0001. Overall, the low iron profile was found in 15 (15%) patients in group A, and in 2 (4%) patients in group B (P-value 0.0559). Both iron and non-iron deficiency anemia were more prevalent among the exacerbation group (group A).

Conclusion

Anemia is a relatively common finding among COPD patients (both IDA and non-IDA). It is more prevalent among those patients developing frequent exacerbations.

References

American Thoracic Society/European Respiratory Society Task Force: Standards for the diagnosis and management of patients with COPD. Version 1.2. New York: American Thoracic Society, 2004. PDF available for download at https://www.thoracic.org/copdguidelines/resources/copddoc.pdf

From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Available from: goldcopd.org.

Lee SJ, Kim SW, Kong KA, Ryu YJ, Lee JH, Chang JH. Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea. Int J Chron Obstruct Pulmon Dis. 2015; 10:497-506. DOI: https://doi.org/10.2147/COPD.S77662

Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000; 117(5 Suppl 2):398S-401S. DOI: https://doi.org/10.1378/chest.117.5_suppl_2.398S

Kendrick S. Emergency admissions: what is driving the increase? Health Serv J. 1995; 105(5451):26-8.

Robalo Nunes A, Tata M. The impact of anaemia and iron deficiency in chronic obstructive pulmonary disease: A clinical overview. Rev Port Pneumol (2006). 2017; 23(3):146-55. DOI: https://doi.org/10.1016/j.rppnen.2016.12.005

GOLD Committees. Global Initiative for Obstructive Lung Disease (GOLD), Introduction, 2011, p. vii. Available on https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf

Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006; 28(3):523-32. DOI: https://doi.org/10.1183/09031936.06.00124605

Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005; 352(10):1011-23. DOI: https://doi.org/10.1056/NEJMra041809

Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest. 2001; 119(6):1691-5. DOI: https://doi.org/10.1378/chest.119.6.1691

Zavarreh RH, Ahmatkesh M, Vakili M, Ahmadi AS, Zohal MA, Arabi M, et al. Association between Anemia and COPD in Iranian Population. IJHOSCR. 2013; 7:1-10.

Hussein MA, Hashim Al-Kadhimi HM. Value of C Reactive Protein Measurements in Exacerbations of Chronic Obstructive Pulmonary Disease. Al -Nahrain College of Medicine ISSN1681-6579.

Aksu F, Capan N, Aksu K, Ofluoglu R, Canbakan S, Yavuz B, et al. C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure. J Thorac Dis. 2013; 5(4):414-21.

Nickol AH, Frise MC, Cheng HY, McGahey A, McFadyen BM, Harris-Wright T, et al. A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease. BMJ Open. 2015; 5(7). DOI: https://doi.org/10.1136/bmjopen-2015-007911

Plesner LL, Schoos MM, Dalsgaard M, Goetze JP, Kjoller E, Vestbo J, et al. Iron Deficiency in COPD Associates with Increased Pulmonary Artery Pressure Estimated by Echocardiography. Heart Lung Circ. 2017; 26(1):101-4. DOI: https://doi.org/10.1016/j.hlc.2016.04.020

Published

2020-09-21

How to Cite

1.
Mahwi T, Aziz B. PREVALENCE AND EFFECT OF IRON DEFICIENCY ANEMIA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE. JSMC [Internet]. 2020 Sep. 21 [cited 2024 May 30];10(2):207-10. Available from: https://jsmc.univsul.edu.iq/index.php/jsmc/article/view/jsmc-10259

Similar Articles

1-10 of 168

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)